PSA 10-20 Gleason 3+4 or 4+3 Clinical Exam: Abnormality that does not extend beyond the boundary of the prostate Management Options Open Radical Prostatectomy Robotic Radical Prostatectomy Radiation Therapy Watchful Waiting Clinical Trials Find National Cancer Institute-Supported Clinical Trials for Intermediate Risk Prostate Cancer